NASDAQ: AIRS
Airsculpt Technologies Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their AIRS stock forecasts and price targets.

Forecast return on equity

Is AIRS forecast to generate an efficient return?

Company
N/A
Industry
-90.38%
Market
231.25%

Forecast return on assets

Is AIRS forecast to generate an efficient return on assets?

Company
N/A
Industry
11.06%

AIRS earnings per share forecast

What is AIRS's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.07
Avg 2 year Forecast
-$0.05

AIRS revenue forecast

What is AIRS's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$159.9M+1.47%
Avg 2 year Forecast
$170.2M+8.05%
Avg 3 year Forecast
$206.8M+31.22%
AIRS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AIRS revenue growth forecast

How is AIRS forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
6.52%
Industry
6.26%
Market
56.22%
AIRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AIRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AIRS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
AIRS$1.85N/AN/A
BTMD$2.47$4.00+61.94%Hold
JYNT$8.85$18.00+103.39%Strong Buy
DCGO$0.89$1.50+68.92%Hold
NAKA$0.41$4.50+1,002.94%Strong Buy

Airsculpt Technologies Stock Forecast FAQ

What is AIRS's earnings growth forecast for 2026-2027?

(NASDAQ: AIRS) Airsculpt Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 19.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 105.43%.

Airsculpt Technologies's earnings in 2026 is -$17,984,000.On average, 4 Wall Street analysts forecast AIRS's earnings for 2026 to be -$4,139,551, with the lowest AIRS earnings forecast at -$4,283,156, and the highest AIRS earnings forecast at -$3,933,510.

In 2027, AIRS is forecast to generate -$3,184,270 in earnings, with the lowest earnings forecast at -$4,283,156 and the highest earnings forecast at -$1,966,755.

If you're new to stock investing, here's how to buy Airsculpt Technologies stock.

What is AIRS's revenue growth forecast for 2026-2028?

(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 6.52% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 56.22%.

Airsculpt Technologies's revenue in 2026 is $157,554,000.On average, 5 Wall Street analysts forecast AIRS's revenue for 2026 to be $9,981,750,433, with the lowest AIRS revenue forecast at $9,025,220,649, and the highest AIRS revenue forecast at $10,666,680,703. On average, 4 Wall Street analysts forecast AIRS's revenue for 2027 to be $10,629,218,701, with the lowest AIRS revenue forecast at $9,245,622,094, and the highest AIRS revenue forecast at $11,977,850,773.

In 2028, AIRS is forecast to generate $12,908,781,523 in revenue, with the lowest revenue forecast at $12,403,044,496 and the highest revenue forecast at $13,289,020,843.

What is AIRS's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: AIRS) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 11.06%.

What is AIRS's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: AIRS) Airsculpt Technologies's current Earnings Per Share (EPS) is -$0.29. On average, analysts forecast that AIRS's EPS will be -$0.07 for 2026, with the lowest EPS forecast at -$0.07, and the highest EPS forecast at -$0.06. In 2027, AIRS's EPS is forecast to hit -$0.05 (min: -$0.07, max: -$0.03).

What is AIRS's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: AIRS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.